BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 35738680)

  • 1. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology.
    de Almeida LGN; Thode H; Eslambolchi Y; Chopra S; Young D; Gill S; Devel L; Dufour A
    Pharmacol Rev; 2022 Jul; 74(3):712-768. PubMed ID: 35738680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
    Rashid ZA; Bardaweel SK
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).
    Almutairi S; Kalloush HM; Manoon NA; Bardaweel SK
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in the CNS: interferons get nervous.
    Chopra S; Overall CM; Dufour A
    Cell Mol Life Sci; 2019 Aug; 76(16):3083-3095. PubMed ID: 31165203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic Roles of Metalloproteinases in Hematological Malignancies: an Update.
    Chaudhary AK; Chaudhary S; Ghosh K; Nadkarni A
    Asian Pac J Cancer Prev; 2016; 17(7):3043-51. PubMed ID: 27509927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
    Li W; Saji S; Sato F; Noda M; Toi M
    Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
    Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
    Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
    Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
    Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase inhibition in atherosclerosis and stroke.
    Roycik MD; Myers JS; Newcomer RG; Sang QX
    Curr Mol Med; 2013 Sep; 13(8):1299-313. PubMed ID: 23865428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy.
    Maurya S; Prasad D; Mukherjee S
    Anticancer Agents Med Chem; 2024; 24(1):3-17. PubMed ID: 37990427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and Function of Human Matrix Metalloproteinases.
    Laronha H; Caldeira J
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Matrix Metalloproteinases by Plant-derived Products.
    Anuar NNM; Zulkafali NIN; Ugusman A
    Curr Cancer Drug Targets; 2021; 21(2):91-106. PubMed ID: 33222671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
    Abdel-Hamid NM; Abass SA
    Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seesaw of matrix metalloproteinases (MMPs).
    Kapoor C; Vaidya S; Wadhwan V; ; Kaur G; Pathak A
    J Cancer Res Ther; 2016; 12(1):28-35. PubMed ID: 27072206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
    Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
    Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.